BIOMAT Database Logo BIOMAT Database Logo

Chemotherapy and intraoperative radiation therapy for operable stage III non-small cell lung cancer. 2016

A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov

The study was undertaken to evaluate results of combined modality treatment including intraoperative radiation therapy (IORT) in 202 patients with stage III non-small cell lung cancer. The 5-year disease-free and overall survival rates in patients who underwent 15 Gy IORT were 18. 7% and 29. 2%, respectively. The overall response rate to preoperative chemotherapy with paclitaxel/carboplatin was 43. 7%, treatment was well tolerated. Preoperative chemotherapy with paclitaxel/ carboplatin in combination with 15 Gy IORT led to a significant increase in the 5-year disease-free and overall survival rates to 31. 4% and 39. 2%, respectively (p<0. 05). The 5-year disease-free and overall survival rates were respectively 32. 6% and 40. 8% in patients who received additional administration of cisplatin combined with 10 Gy IORT. Radiosensibilization with cisplatin in patients treated with 15 Gy IORT increased the 5-year disease-free and overall survival rates to 41. 7% and 47. 9%, respectively (p<0. 05).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Radiation and chemotherapy for patients with stage III non-small cell lung cancer.
October 2000, Seminars in radiation oncology,
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer.
June 2023, Scientific reports,
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
February 2020, Acta oncologica (Stockholm, Sweden),
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer.
April 2017, Translational lung cancer research,
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer.
January 2009, Lung cancer (Amsterdam, Netherlands),
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Radiation therapy for stage III non-small cell lung cancer invading chest wall.
October 1997, Lung cancer (Amsterdam, Netherlands),
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Chemotherapy in stage III non-small cell lung cancer.
September 2009, European journal of cancer (Oxford, England : 1990),
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Chemotherapy and radiation therapy as compared with radiation therapy in stage III non-small-cell cancer.
April 1991, The New England journal of medicine,
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Hypofractionated radiation therapy in unresectable stage III non-small cell lung cancer.
September 1993, Cancer,
A Y Dobrodeev, and A A Zaviyalov, and S A Tuzikov
Treatment of stage III non-small cell lung cancer with thoracic radiation therapy and simultaneous platinum chemotherapy.
June 1994, Seminars in oncology,
Copied contents to your clipboard!